Rhythm Pharmaceuticals, Inc. (RYTM)
USD 46.67
(-6.32%)
USD 46.67
(-6.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 77.42 Million | 23.63 Million | 3.15 Million | - | - | - |
| Cost of Revenue | 9.3 Million | 2.13 Million | 599 Thousand | 690 Thousand | 834 Thousand | 442 Thousand |
| Gross Profit | 68.12 Million | 21.5 Million | 2.55 Million | -690 Thousand | -834 Thousand | -442 Thousand |
| Operating Expenses | 252.48 Million | 200.66 Million | 172.61 Million | 136.57 Million | 146 Million | 78.41 Million |
| Selling, General and Administrative Expenses | 117.53 Million | 92.03 Million | 68.48 Million | 46.12 Million | 36.55 Million | 28.08 Million |
| Research and Development Expenses | 134.95 Million | 108.63 Million | 104.12 Million | 90.45 Million | 109.45 Million | 50.33 Million |
| Other Expenses | - | -790 Thousand | 100 Million | - | - | - |
| Cost and Expenses | 261.78 Million | 202.79 Million | 173.21 Million | 136.57 Million | 146 Million | 78.41 Million |
| Operating Income | -184.35 Million | -179.15 Million | -170.05 Million | -136.57 Million | -146 Million | -78.41 Million |
| Interest Expense | 13.89 Million | 5.2 Million | - | - | - | - |
| Income Tax Expense | 564 Thousand | 1.96 Million | -1.6 Million | -3.26 Million | -6.1 Million | 4.35 Million |
| Earnings before Tax | -184.11 Million | -181.11 Million | -69.61 Million | -133.99 Million | -140.72 Million | -74.06 Million |
| Net Income | -184.67 Million | -183.08 Million | -68 Million | -130.72 Million | -134.62 Million | -74.06 Million |
| Earnings Per Share Basic | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 |
| Earnings Per Share Diluted | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 |
| Weighted Average Shares Outstanding | 57.67 Million | 52.12 Million | 49.6 Million | 44.12 Million | 36.42 Million | 31 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.67 Million | 52.12 Million | 49.6 Million | 44.12 Million | 36.42 Million | 31 Million |
| Gross Margin | 0.88 | 0.91 | 0.81 | - | - | - |
| EBIT Margin | -2.18 | -7.44 | -53.92 | - | - | - |
| Profit Margin | -2.39 | -7.75 | -21.56 | - | - | - |
| EBITDA | -168.46 Million | -174.51 Million | -68.45 Million | -135.88 Million | -145.16 Million | -77.97 Million |
| Earnings Before Tax Margin | -2.38 | -7.58 | -53.92 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 29.07 Million | 25.96 Million | 24.23 Million | 77.42 Million | 22.5 Million | 19.22 Million |
| Cost of Revenue | 3.12 Million | 2.99 Million | 3.23 Million | 9.3 Million | 2.41 Million | 2.23 Million |
| Gross Profit | 25.95 Million | 22.96 Million | 21 Million | 68.12 Million | 20.09 Million | 16.98 Million |
| Operating Expenses | 66.43 Million | 162.85 Million | 62.26 Million | 252.48 Million | 64.04 Million | 63.58 Million |
| Selling, General and Administrative Expenses | 36.41 Million | 34.38 Million | 32.37 Million | - | 30.47 Million | 30.04 Million |
| Research and Development Expenses | 30.01 Million | 128.47 Million | 29.89 Million | - | 33.57 Million | 33.54 Million |
| Other Expenses | 302 Thousand | 524 Thousand | 559 Thousand | 190 Thousand | -159 Thousand | -17 Thousand |
| Cost and Expenses | 69.55 Million | 165.85 Million | 65.49 Million | 261.78 Million | 66.45 Million | 65.82 Million |
| Operating Income | -40.47 Million | -139.88 Million | -41.26 Million | -184.35 Million | -43.95 Million | -46.6 Million |
| Interest Expense | 4.6 Million | 4.75 Million | 4.55 Million | 13.89 Million | 3.14 Million | 3.3 Million |
| Income Tax Expense | 479 Thousand | 300 Thousand | 196 Thousand | 564 Thousand | 368 Thousand | 82 Thousand |
| Earnings before Tax | -31.78 Million | -141.07 Million | -41.43 Million | -184.11 Million | -43.79 Million | -46.7 Million |
| Net Income | -32.26 Million | -141.37 Million | -41.63 Million | -184.67 Million | -44.16 Million | -46.7 Million |
| Earnings Per Share Basic | -0.53 | -2.35 | -0.70 | - | -0.76 | -0.82 |
| Earnings Per Share Diluted | -0.53 | -2.35 | -0.70 | - | -0.76 | -0.82 |
| Weighted Average Shares Outstanding | 61.01 Million | 60.14 Million | 59.21 Million | 57.67 Million | 57.87 Million | 56.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.01 Million | 60.14 Million | 59.21 Million | 57.67 Million | 57.87 Million | 56.86 Million |
| Gross Margin | 0.89 | 0.88 | 0.87 | 0.88 | 0.89 | 0.88 |
| EBIT Margin | -1.38 | -5.37 | -1.50 | - | -1.81 | -2.26 |
| Profit Margin | -1.11 | -5.44 | -1.72 | -2.39 | -1.96 | -2.43 |
| EBITDA | -40.08 Million | -139.48 Million | -36.47 Million | - | -40.64 Million | -43.4 Million |
| Earnings Before Tax Margin | -1.39 | -5.39 | -1.70 | -2.38 | -1.95 | -2.42 |
TNTLF
ALA
NEWINFRA
GALP
ONTEX
VHI